Biotech Co.*
(Country; Symbol)
Pharma Co.
Country)
Type/Product Area Terms/Details (Date)

JUNE
 
Apthera Inc.* Kwang Dong Pharmaceutical Co. Ltd. (South Korea) Licensing agreement for NeuVax in South Korea for breast cancer Apthera will receive equity investments as well as milestone and royalty payments (6/4)
 
Elusys Therapeutics* Lonza Sales AG (Switzerland)  Agreement for the production of Anthim, a therapeutic monoclonal antibody in late-stage development for the treatment  of anthrax infection Lonza will provide process development services and manufacturing capacity for that product using Lonza's GS Gene Expression System (6/16)
 
JULY
 
BioAlliance Pharma SA (France; Paris:BIO) H. Lundbeck A/S (Denmark) Agreement to co-promote the antidepressant Seroplex Efforts will be aimed at core health care partners; financial terms were not disclosed (7/21)
 
NewBridge Pharmaceuticals* Axcan Pharma Inc. (Canada) Exclusive license and supply agreement for Pylera, a 3-in-1 capsule therapy for the treatment of Helicobacter pylori NewBridge is entitled to obtain exclusive rights in certain markets where it obtains required regulatory approvals and launches the product (7/22)

Notes:

# The information in the chart does not cover agricultural agreements or those between biotech companies. * Private companies are indicated with an asterisk. Unless otherwise noted, stock symbols listed are on the Nasdaq market.